Skip to content
Search

Latest Stories

Top Stories

There is no magic pill for postpartum depression

There is no magic pill for postpartum depression
Getty Images

Priya Iyer is the founder of Our Roots, a non-profit that virtually connects BIPOC, low-income pregnant and postpartum communities to peer support coaches to prevent perinatal anxiety and depression. She holds an MPH in Epidemiology from Columbia University, and she is a Public Voices Fellow with the OpEd Project in partnership with the National Black Child Development Institute.

The FDA recently approved the first oral drug for postpartum depression, Zurzuvae. At first glance, this seems like especially good news for women and birthing people of color, who are twice as likely to experience perinatal mood disorders as compared to White women (further compounded if they are low-income). However, supporting people with perinatal depression is much more complex than popping a pill. A drug cannot replace or mask the systemic issues faced by those who need support the most.


We should stop overhyping Zurzuvae’s potential impact, when it may be inaccessible to those it is supposed to benefit. Like many other patented drugs, the cost will be potentially prohibitive. Additionally, BIPOC communities are often misdiagnosed or underdiagnosed for postpartum depression by the same clinicians whom we are relying on to prescribe the pill. This is due to a range of reasons from limited provider training on culturally-responsive care to implicit biases. An abundance of evidence shows us potential pathways to addressing disparities in health.

Sign up for The Fulcrum newsletter

Yet, the U.S. healthcare system promotes profit for pharmaceutical companies over investment in proven solutions, which comes at a cost. For each mother-baby pair affected by and untreated for a perinatal mood disorder, the financial toll for society is $31,800. Sage Therapeutic (the maker of Zurzuvae) has said the price for the drug will be around $10,000. With their estimate that 400,000 people are impacted by postpartum depression, the cost of treating these birthing people each year is $4,000,000,000 to payers, which includes a projected, handsome $1.35 billion revenue stream for Sage by 2032.

At half the amount, we could offer preventative solutions to all four million people giving birth each year, including some tailored to BIPOC and low-income communities. As the founder of Our Roots, a social enterprise that connects BIPOC, low-income birthing people to peer support coaches who share lived experiences, we are able to prevent depression and anxiety at the cost of $500 per mother baby pair, and likely much less on a larger scale. These preventative and systemic fixes are far more likely to benefit those who need access the most as well as the general population.

I’ve worked as a part of an access solution program at a pharmaceutical company and have seen when underinsured or uninsured people are desperately in need of medication because preventative solutions have failed them. Pharmaceutical companies claim they will make Zurzuvae available through such access programs. However, in my experience, access programs serve primarily as marketing and branding opportunities for pharmaceutical companies. They serve as a patchwork solution without addressing the root problem of prohibitively and unnecessarily high drug costs (3.44 times the amount of brand-named drugs in comparable nations).

As both a BIPOC mother of two—who experienced a perinatal mood disorder—and a maternal and child health epidemiologist, I know that a combination of culturally-responsive doctors, therapists, and extensive group and individual peer and community support has been proven to both prevent and treat perinatal mood disorders. There is no magic pill that can dismantle the systems of oppression that exist in our healthcare systems and instead build systems truly tailored to the diverse fabric of our society. While systemic injustice continues to exist, we should ask ourselves who Zurzuvae will truly benefit.

Read More

"Swing state" sign under a cutout of Pennsylvania
gguy44/Getty Images

Election Overtime project prepares Pennsylvania media for Nov. 5

A new set of complementary tools designed to support accurate reporting of contested elections will be unveiled by the Election Reformers Network and other election law experts on Wednesday.

The Election Overtime project will provide journalists covering Pennsylvania’s 2024 general election with media briefings by election specialists; guides for reporting on election transparency, verification processes and judicial procedures; and an extensive speakers bureau. The briefing is designed for journalists but is open to the public. Register now.

Keep ReadingShow less
Hispanic family

Rafael Mendez and his family.

Courtesy Rafael Mendez

U.S. Hispanic voters: Breaking the monolith myth

Macias, a former journalist with NBC and CBS, owns the public relations agencyMacias PR.

The Fulcrum presents We the People, a series elevating the voices and visibility of the persons most affected by the decisions of elected officials. In this installment, we explore the motivations of over 36 million eligible Latino voters as they prepare to make their voices heard in November.

According to the Census Bureau, the Hispanic, Latino population makes up the largest racial or ethnic minority group in America. But this group is not a monolith. Macias explores providing a more accurate and nuanced understanding of this diverse population.

Several new political polls examine how Hispanic voters view former President Donald Trump and Vice President Kamala Harris. Not surprisingly, the polls are all over the place, even though they were taken around the same time.

Keep ReadingShow less
Jimmy Carter watching election procedures

Former President Jimmy Carter observes voting procedures in Port-au-Prince, Haiti, in 1990.

Cynthia Johnson/Liaison

Celebrate Jimmy Carter’s 100th birthday and his work on elections

Merloe provides strategic advice on elections and democracy in the United States and internationally. He worked with former President Jimmy Carter on elections and democratic transitions on four continents.

On Oct. 1, President Jimmy Carter turns 100 years old. According to reports, he is concerned about the dynamics surrounding the 2024 election and hopeful that the United States will turn the page. That is no surprise given his devotion to this country and his dedication to fostering genuine elections around the world.

Keep ReadingShow less
Young businessman holding his head and pondering
Hinterhaus Productions/Getty Images

When should you start worrying?

Chaleff is a speaker, innovative thinker and the author of “To Stop a Tyrant: The Power of Political Followers to Make or Brake a Toxic Leader.” This is the fifth entry in a series on political followership.

We recently read in The Washington Post that men in Afghanistan are regretting that they did not stand up sooner for the rights of their wives and daughters, now that the Taliban is imposing severe standards of dress and conduct on them.

Duh.

That’s the oldest regret there is when it comes to oppression:

Keep ReadingShow less